SCHEMBL14770569

SCHEMBL14770569

c1cc(-c2ccc3oc4ccccc4c3c2)nc(-c2ccc3oc4ccc(-n5c6ccccc6c6ccccc65)cc4c3c2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
CHEK2 O96017 1/20 0.38
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AHR P35869 2/20 0.35
PTPRF P10586 5/20 0.34
PTPN2 P17706 5/20 0.34
PTPN1 P18031 5/20 0.34
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041340 0.97 KDM4E (0.38) KDM4ENPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14770636 0.95 CASP3 (0.36) KDM4ENPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL15294180 0.94 CHEK2 (0.35) KDM4ENPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14770629 0.94 KDM4E (0.38) KDM4ENPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14867943 0.91 KMT2A (0.38) KDM4EMAPTALDH1A1MEN1HPGD
SCHEMBL14770574 0.91 KDM4E (0.43) KDM4EMEN1RAB9AKMT2ACHEK2
SCHEMBL14770575 0.91 ALOX5 (0.41) NPC1MAPTCHEK2ATMPTPRF
SCHEMBL14867964 0.91 CHEK2 (0.34) KDM4ENPC1MAPTSMN1; SMN2ALDH1A1
SCHEMBL14770637 0.90 PTPRF (0.34) KDM4ECHEK2CASP3SENP7SENP6
SCHEMBL14770645 0.90 KMT2A (0.37) KDM4ENPC1MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L KDM4E 1763/4885NPC1 3134/4885MAPT 2242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.